Brain Fog News and Research

RSS

NIH launches and opens enrollment for phase 2 clinical trials to evaluate long COVID treatments

Today, the National Institutes of Health launched and is opening enrollment for phase 2 clinical trials that will evaluate at least four potential treatments for long COVID, with additional clinical trials to test at least seven more treatments expected in the coming months.

31 Jul 2023

Research uncovers new insights into post-COVID-19 syndrome (PCS) phenotypes and impact on quality of life

Researchers assessed post-coronavirus disease 2019 (COVID-19) syndrome (PCS) prevalence and severity.

26 Jul 2023

Comparing COVID-19 symptom burden and quality of life in positive and negative PCR test results

Reports evaluated to what extent symptoms are present before, during, and after a positive SARS-CoV-2 PCR test.

24 Jul 2023

NIAID funds research to better understand Post-treatment Lyme Disease Syndrome

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded five projects for research to better understand Post-treatment Lyme Disease Syndrome (PTLDS), which is a collection of symptoms, such as pain, fatigue, and difficulty thinking or "brain fog," which linger following standard treatment for Lyme disease.

21 Jul 2023

Long COVID can affect brain function for years after infection

UK researchers have found that people with longer-term COVID-19 symptoms including brain fog showed reduced performance in tasks testing different mental processes up to two years after infection with the virus.

21 Jul 2023

Self-reported long COVID symptoms not identified in diagnostic tests

Researchers describe chronic symptoms related to physical or mental functioning following SARS-CoV-2 infection.

12 Jul 2023

Unique blood protein patterns in long COVID patients could reveal potential drug targets

Recently published in The Journal of Translational Medicine, a team at Lawson Health Research Institute has discovered unique patterns of blood plasma proteins in patients with long COVID that could reveal potential drug targets to improve patient outcomes.

7 Jul 2023

Women with post-acute sequelae of COVID-19 could be at greater risk of developing hypertension

Post-acute sequelae of COVID-19 (PASC), colloquially referred to as long COVID-19 or long COVID, is when someone recovers from acute COVID-19 but shows a cluster of symptoms for months afterward.

4 Jul 2023

Molecular insights into long COVID: serum proteome reveals dominant signaling pathways

Researchers examined the serum proteome of unvaccinated adults who had PASC.

15 Jun 2023

Beyond exhaustion: study identifies fatigue as key factor limiting functionality in long COVID patients

Researchers assess self-documented long COVID symptoms among care-seeking individuals.

13 Jun 2023

Long Covid-related fatigue impacts daily lives of patients more than some cancers

Fatigue is the symptom that most significantly impacts the daily lives of long Covid patients, and can affect quality of life more than some cancers, finds a new study led by researchers at UCL and the University of Exeter.

7 Jun 2023

Unraveling the complexity of 'Long-COVID' and its impact on breathing

More than a third of COVID-19 patients experience long-lasting symptoms, known as post-COVID-19 condition or long COVID, with breathlessness being a commonly reported symptom. Pulmonary complications, such as fibrosis and thromboembolic disease, require careful assessment, and non-pharmacological interventions like pulmonary rehabilitation can help manage breathlessness.

5 Jun 2023

Is healthy sleep, both before and during the COVID-19 pandemic, prior to SARS-CoV-2 infection, protective against post–COVID-19 condition?

Researchers examined the relationship between multidimensional sleep health and post-coronavirus disease 2019 condition.

1 Jun 2023

Defining long-COVID using self-reported symptoms

Researchers developed a symptom-based criteria to identify post-acute sequelae of SARS-CoV-2 infection.

30 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

Study elucidates 12 defining symptoms of long COVID

Long COVID, or Post-Acute Sequelae of SARS-CoV-2 infection (PASC), includes a wide range of symptoms that present or persist more than 30 days after COVID-19 infection.

25 May 2023

Post-COVID condition varies by variant and vaccination status

Research investigates the post-COVID-19 condition, analyzing its profiles based on viral variants and vaccination status. Understanding these profiles can aid in personalized patient care.

17 May 2023

Long COVID risk may increase with low levels of vitamin D

Long COVID risk has been found to increase with low levels of vitamin D, according to research presented at the 25th European Congress of Endocrinology in Istanbul.

13 May 2023

Hyperbaric oxygen therapy can be beneficial in patients with post-COVID syndrome

A small randomized trial in patients with post-COVID syndrome has found that hyperbaric oxygen therapy promotes restoration of the heart's ability to contract properly. The research is presented at EACVI 2023, a scientific congress of the European Society of Cardiology.

10 May 2023